Purchase Order 36C25225P0802
Award Date
5/27/25
Potential Completion Date
6/26/25
Potential Value
$50K
Federal Agency
Veterans Integrated Service Network 12
Awardee
Novocure Inc.
Ultimate Awardee
Not listed
NAICS Category
339113 - Surgical Appliance and Supplies Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The...
This federal contract award to Novocure Inc. is for the procurement of the company's Optune Plus Transducers product line, a cancer therapy device that delivers Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The $49,748.73 firm fixed-price contract was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and is not set aside. Novocure, a foreign-owned for-profit manufacturer, holds a 5-year Federal Supply Schedule (FSS) contract...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of TFH 9000 OPTUNE PLUS TRANSDUCERS for the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $84,000.00 firm fixed-price purchase order, awarded on June 29, 2020, has an ultimate completion date of December 29, 2020. The contract does not utilize any set-aside designations. Novocure is the prime contractor and is delivering its...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The contract, valued at $49,748.73, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under its Federal Supply Schedule (FSS) program. The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 delivery order contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract is part of a larger $28.85 million Federal Supply Schedule (FSS)...
This federal contract award is for the procurement of Optune Plus transducers from Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $16,582.91 firm-fixed price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc. as the prime contractor. The contract has an ultimate completion date of March 28, 2025 and does not utilize any set-aside designations. Novocure...
This federal contract award is for the procurement of Novocure's Optune device, a cancer treatment technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract, valued at $49,748.73, was awarded to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), specifically the Veterans Integrated Service Network 12 (VISN 12). The contract is...
This federal contract award is for Novocure Inc., a foreign-owned, for-profit medical device manufacturer, to provide the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with its Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract, valued at $16,582.91, is a firm fixed-price delivery order awarded under Novocure's $28.85 million Federal Supply Schedule...
This federal contract award is for the provision of Novocure Inc.'s proprietary Optune Tumor Treating Fields (TTFields) therapy products and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price delivery order was issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. The contract does not utilize any set-aside designations....
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, a component of the company's Tumor Treating Fields (TTFields) cancer therapy technology, over a 3-month period. This award is part of a larger $28.85 million Federal Supply Schedule (FSS)...